Is Sharda Cropchem overvalued or undervalued?

As of 4 September 2025, Sharda Cropchem's valuation grade has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued. Key ratios supporting this assessment include a PE ratio of 19.34, an EV to EBITDA of 10.53, and a PEG ratio of 0.11, which suggests strong growth potential relative to its price.
In comparison with peers, Sharda Cropchem's PE ratio is significantly lower than that of P I Industries, which stands at 35.21, and Bayer CropScience at 38.78, both of which are categorized as expensive. Additionally, UPL, another attractive peer, has a PE ratio of 34.82, further emphasizing Sharda's relative undervaluation. Notably, Sharda Cropchem has outperformed the Sensex over the past year with a return of 59.22% compared to the Sensex's decline of 1.98%, reinforcing its attractive valuation.